OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Duration of new antidepressant use and factors associated with discontinuation among community-dwelling persons with Alzheimer’s disease
Reetta Kettunen, Heidi Taipale, Anna‐Maija Tolppanen, et al.
European Journal of Clinical Pharmacology (2018) Vol. 75, Iss. 3, pp. 417-425
Open Access | Times Cited: 11
Reetta Kettunen, Heidi Taipale, Anna‐Maija Tolppanen, et al.
European Journal of Clinical Pharmacology (2018) Vol. 75, Iss. 3, pp. 417-425
Open Access | Times Cited: 11
Showing 11 citing articles:
Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
Sube Banerjee, Juliet High, Susan Stirling, et al.
The Lancet (2021) Vol. 398, Iss. 10310, pp. 1487-1497
Open Access | Times Cited: 52
Sube Banerjee, Juliet High, Susan Stirling, et al.
The Lancet (2021) Vol. 398, Iss. 10310, pp. 1487-1497
Open Access | Times Cited: 52
Prolonged Use of Antidepressants Among Older People Residing in Long-Term Care Facilities
Georgina A. Hughes, Maria C. Inacio, Debra Rowett, et al.
Journal of the American Medical Directors Association (2025) Vol. 26, Iss. 4, pp. 105482-105482
Closed Access
Georgina A. Hughes, Maria C. Inacio, Debra Rowett, et al.
Journal of the American Medical Directors Association (2025) Vol. 26, Iss. 4, pp. 105482-105482
Closed Access
The value of deprescribing in older adults with dementia: a narrative review
Mouna Sawan, Daniela C. Moga, J. Megan, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 11, pp. 1367-1382
Closed Access | Times Cited: 25
Mouna Sawan, Daniela C. Moga, J. Megan, et al.
Expert Review of Clinical Pharmacology (2021) Vol. 14, Iss. 11, pp. 1367-1382
Closed Access | Times Cited: 25
A geroscience motivated approach to treat Alzheimer’s disease: Senolytics move to clinical trials
Mitzi M. Gonzales, Sudarshan Krishnamurthy, Valentina R. Garbarino, et al.
Mechanisms of Ageing and Development (2021) Vol. 200, pp. 111589-111589
Open Access | Times Cited: 24
Mitzi M. Gonzales, Sudarshan Krishnamurthy, Valentina R. Garbarino, et al.
Mechanisms of Ageing and Development (2021) Vol. 200, pp. 111589-111589
Open Access | Times Cited: 24
Sociodemographics and clinical factors associated with depression treatment outcomes in 65,741 first-time users of selective serotonin reuptake inhibitors: A Danish cohort study in older adults
Kazi Ishtiak‐Ahmed, Kaj Sparle Christensen, Erik Lykke Mortensen, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 244-254
Open Access | Times Cited: 2
Kazi Ishtiak‐Ahmed, Kaj Sparle Christensen, Erik Lykke Mortensen, et al.
Journal of Affective Disorders (2024) Vol. 367, pp. 244-254
Open Access | Times Cited: 2
Gender Differences in Function, Physical Activity, Falls, Medication Use, and Life Satisfaction Among Residents in Assisted Living Settings
Barbara Resnick, Marie Boltz, Elizabeth Galik, et al.
Research in Gerontological Nursing (2019) Vol. 13, Iss. 1, pp. 31-40
Open Access | Times Cited: 15
Barbara Resnick, Marie Boltz, Elizabeth Galik, et al.
Research in Gerontological Nursing (2019) Vol. 13, Iss. 1, pp. 31-40
Open Access | Times Cited: 15
A pragmatic, multicentre, double-blind, placebo-controlled randomised trial to assess the safety, clinical and cost-effectiveness of mirtazapine and carbamazepine in people with Alzheimer’s disease and agitated behaviours: the HTA-SYMBAD trial
Sube Banerjee, Nicolas Farina, Catherine Henderson, et al.
Health Technology Assessment (2023), pp. 1-108
Open Access | Times Cited: 4
Sube Banerjee, Nicolas Farina, Catherine Henderson, et al.
Health Technology Assessment (2023), pp. 1-108
Open Access | Times Cited: 4
Association of recent hospitalisation with antidepressant initiation among community dwellers with Alzheimer's disease
Anniina Tarvainen, Sirpa Hartikainen, Heidi Taipale, et al.
International Journal of Geriatric Psychiatry (2021) Vol. 36, Iss. 7, pp. 1075-1084
Open Access | Times Cited: 6
Anniina Tarvainen, Sirpa Hartikainen, Heidi Taipale, et al.
International Journal of Geriatric Psychiatry (2021) Vol. 36, Iss. 7, pp. 1075-1084
Open Access | Times Cited: 6
Identifying temporal patterns of adherence to antidepressants, bisphosphonates and statins, and associated patient factors
Kyu Hyung Park, Leonie Tickle, Henry Cutler
SSM - Population Health (2021) Vol. 17, pp. 100973-100973
Open Access | Times Cited: 5
Kyu Hyung Park, Leonie Tickle, Henry Cutler
SSM - Population Health (2021) Vol. 17, pp. 100973-100973
Open Access | Times Cited: 5
Pinus halepensis Essential Oil Ameliorates Aβ1-42-Induced Brain Injury by Diminishing Anxiety, Oxidative Stress, and Neuroinflammation in Rats
Paula Alexandra Postu, Marius Mihășan, Lucian Gorgan, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2300-2300
Open Access | Times Cited: 3
Paula Alexandra Postu, Marius Mihășan, Lucian Gorgan, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2300-2300
Open Access | Times Cited: 3
Antidepressant discontinuation patterns and characteristics across sociodemographic groups in the United States
Yoojung Kwon, Julie C. Lauffenburger
Journal of Affective Disorders (2024) Vol. 355, pp. 82-85
Closed Access
Yoojung Kwon, Julie C. Lauffenburger
Journal of Affective Disorders (2024) Vol. 355, pp. 82-85
Closed Access
